机构:[1]Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China[2]Hebei Med Univ, Dept Basic Med, Shijiazhuang, Hebei, Peoples R China[3]Hebei Univ Engn, Affiliated Hosp, Handan, Peoples R China[4]Hebei Med Univ, Hosp 2, Neurosurg Dept, Shijiazhuang, Hebei, Peoples R China[5]Hebei Med Univ, Med & Hlth Inst, Neurosci Res Ctr, Shijiazhuang, Hebei, Peoples R China
Objective: Multiple mechanisms including vascular endothelial cell damage have a critical role in the formation and development of atherosclerosis (AS), but the specific molecular mechanisms are not exactly clarified. This study aims to determine the possible roles of proline-rich tyrosine kinase 2 (Pyk2)/mitochondrial calcium uniporter (MCU) pathway in AS mouse model and H2O2-induced endothelial cell damage model and explore its possible mechanisms. Approach and Results: The AS mouse model was established using apolipoprotein E-knockout (ApoE(-/-)) mice that were fed with a high-fat diet. It was very interesting to find that Pyk2/MCU expression was significantly increased in the artery wall of atherosclerotic mice and human umbilical vein endothelial cells (HUVECs) attacked by hydrogen peroxide (H2O2). In addition, down-regulation of Pyk2 by short hairpin RNA (shRNA) protected HUVECs from H2O2 insult. Furthermore, treatment with rosuvastatin on AS mouse model and H2O2-induced HUVEC injury model showed a protective effect against AS by inhibiting the Pyk2/MCU pathway, which maintained calcium balance, prevented the mitochondrial damage and reactive oxygen species production, and eventually inhibited cell apoptosis. Conclusion: Our results provide important insight into the initiation of the Pyk2/MCU pathway involved in AS-related endothelial cell damage, which may be a new promising target for atherosclerosis intervention.
基金:
National Natural Science Foundation of China [81571160]; Ministry of Human Resources and Social Security of People's Republic of China [CG2016003003]
第一作者机构:[1]Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China[2]Hebei Med Univ, Dept Basic Med, Shijiazhuang, Hebei, Peoples R China
通讯作者:
通讯机构:[1]Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China[5]Hebei Med Univ, Med & Hlth Inst, Neurosci Res Ctr, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
Zhang Yingzhen,Yang Xiaoli,Li Zhongzhong,et al.Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis[J].FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.2021,9:doi:10.3389/fcell.2021.651579.
APA:
Zhang, Yingzhen,Yang, Xiaoli,Li, Zhongzhong,Bu, Kailin,Li, Tong...&Liu, Xiaoyun.(2021).Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis.FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY,9,
MLA:
Zhang, Yingzhen,et al."Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis".FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 9.(2021)